- Home
- SXTC vs BCIC Comparison
SXTC vs BCIC Comparison
Compare SXTC & BCIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SXTC | BCIC |
|---|---|---|
| Founded | 2005 | 2006 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.9M | 86.9M |
| IPO Year | 2017 | 2006 |
Fundamental Metrics
Financial Performance| Metric | SXTC | BCIC |
|---|---|---|
| Price | $3.30 | $7.66 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | ★ 55.0M | 49.8K |
| Earning Date | 08-19-2019 | 05-07-2026 |
| Dividend Yield | N/A | ★ 14.14% |
| EPS Growth | N/A | ★ 262.50 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $0.00 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.03 | $6.70 |
| 52 Week High | $6.98 | $13.50 |
Technical Indicators
Market Signals| Indicator | SXTC | BCIC |
|---|---|---|
| Relative Strength Index (RSI) | 69.11 | 66.88 |
| Support Level | $1.95 | $7.02 |
| Resistance Level | $6.40 | $7.80 |
| Average True Range (ATR) | 0.17 | 0.20 |
| MACD | 0.42 | 0.07 |
| Stochastic Oscillator | 76.61 | 83.88 |
Price Performance
Historical ComparisonAbout SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly TCMP (Directed-oral TCMP and After-soaking TCMP), which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
About BCIC BCP Investment Corporation
BCP Investment Corp is an externally managed, non-diversified closed-end investment company. The company invests in secured term loans, bonds or notes and mezzanine debt in privately-held middle market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt and selected equity investments in privately-held middle market companies.